inert 1 MG Oral Tablet
- RxCUI
- 748797
- RxNorm name
- inert 1 MG Oral Tablet
- Display name
- inert 1 MG Oral Tablet
- Full name
- inert 1 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals, Inc. | 90240210-0bca-4a55-99dc-19f2b40d8e3f | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 748797 |
| SLYND | DROSPIRENONE | Exeltis USA, Inc. | db32bc55-f295-4d87-9dbb-0a2f45573dcf | 2026-08-27 | Warnings, Adverse reactions | 748797 |
| Isibloom | DESOGESTREL AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 4a8f278f-f505-4537-8deb-74e8927df8c6 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Redpharm Drug | 57d1d945-9fc9-4e79-e063-6294a90a738a | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 748797 |
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 2385591b-70ee-0577-e063-6394a90a9357 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Desogestrel and Ethinyl Estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | 78454ebf-f1a3-4ca0-b32e-88c51bc57773 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6422dcc3-959a-4590-9ca8-9dcb58e68253 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Turqoz | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e7a05138-91a5-4c66-a915-614576e0805a | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Kurvelo | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 752f525e-1838-4058-9ab7-2c2d91f86dfd | 2026-05-20 | Boxed warning, Warnings | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Apotex Corp. | 9187a357-e95d-4733-9627-f19522b86373 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Wera | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Dasetta 7/7/7 | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | da52e74a-1baf-4a33-a068-b49176700320 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Vestura | DROSPIRENONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f73ece43-6b5f-4abb-ba6d-4d62775f2f8e | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIENVA TM | LEVONORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f6825c1a-ba78-47aa-9622-12e59517ab1a | 2026-03-03 | Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Lutera | LEVONORGESTREL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | 47fc432b-2259-47d2-bba9-5e3aae583990 | 2026-02-13 | Warnings, Adverse reactions | 748797 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b7b8ae08-3fb0-4c6c-af02-89f0f6f40ffb | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use SETLAKIN safely and effectively. See full prescribing information for SETLAKIN. SETLAKIN (levonorgestrel and ethinyl estradiol tablets) for oral use Initial U.S. Approval:1982 | 20251205 |
| be7000f1-5bf1-4de5-a256-e4436c37f0a1 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | LEVONEST™ (Levonorgestrel and Ethinyl Estradiol Tablets USP, Triphasic Regimen) | 20251205 |
| 84a20017-344b-4684-a915-c85a55fcbbcb | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use Mono-Linyah safely and effectively. See full prescribing information for Mono-Linyah. Mono-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval:1989 | 20250120 |
| a8c718cc-e235-4710-a9e6-6c58433f3028 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use LO-ZUMANDIMINE safely and effectively. See full prescribing information for LO-ZUMANDIMINE. LO-ZUMANDIMINE™ (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20231009 |
| b31bd776-3926-4b77-aa29-f5a8eef611aa | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | Nylia ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets, USP) 1 mg/0.035 mg Rx only | 20220907 |
| ddbeb312-af2b-4d22-ab7c-5ab2f3f8d5cb | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use TRI-LO-SPRINTEC safely and effectively. See full prescribing information for TRI-LO-SPRINTEC. TRI-LO-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets for oral use Initial U.S. Approval: 1989 | 20211231 |
| 6e8bec6f-17ba-4b37-ae6c-07657815f248 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20251209 |
| 9aff6034-044c-466d-bf52-18a998d47f66 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use NIKKI safely and effectively. See full prescribing information for NIKKI. NIKKI TM (Drospirenone / ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20251208 |
| 77b8d3ef-f3ac-4148-84f0-f6cb327c9f78 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | PHILITH TM (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.4 mg/0.035 mg 28-Day Regimen Rx Only | 20251205 |
| b716fd2a-b186-447a-85bd-6302284d14e5 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Pimtrea TM Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and 0.01 mg | 20251205 |
| 1f8b9aad-f31f-4cda-861d-c08a977fc923 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20251001 |
| 90240210-0bca-4a55-99dc-19f2b40d8e3f | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250924 |
| b0c1a495-4cd7-4664-8fe4-714812f53c71 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | SRONYX ® (Levonorgestrel and Ethinyl Estradiol Tablets USP) | 20250724 |
| db32bc55-f295-4d87-9dbb-0a2f45573dcf | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use SLYND safely and effectively. See full prescribing information for SLYND. SLYND ® (drospirenone) tablets, for oral use Initial U.S. Approval: 2001 | 20250701 |
| 00dd9b78-dd90-414b-b241-7619aa9d1ed2 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250408 |
| cf6f069e-4b78-4adb-b5be-100b9d85aab7 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Rx only | 20250221 |
| 13bdc226-ecf8-4fd7-aa0e-ec19b6b74fc3 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250104 |
| 58ea31df-f9cf-7d00-c2db-0529fb9a3e53 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Vienva ® (levonorgestrel and ethinyl estradiol tablets, USP) 0.1 mg/0.02 mg Rx only | 20241111 |
| dbe9f9ab-2e38-49e3-bb1f-c8a12d03076a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Kalliga™ (Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg) Rx only | 20241102 |
| 4ade84c1-e172-443f-aac7-0e8407aaa7de | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | NYLIA 7/7/7 | 20241025 |
| f1a3bfe0-1057-4120-be7e-d7b3570d5418 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Levonorgestrel and Ethinyl Estradiol Tablets USP Rx only | 20240422 |
| da872266-d5f2-35df-096e-341f58d93427 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use Loryna (drospirenone and ethinyl estradiol tablets) safely and effectively. See full prescribing information for Loryna (drospirenone and ethinyl estradiol tablets). Loryna ® (Drospirenone and Ethinyl Estradiol Tablets, USP) 3 mg/0.02 mg, for oral use Initial U.S. Approval: 2001 | 20230710 |
| 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20230328 |
| 867c5630-51be-4469-bf79-6a5cd4302cfa | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | Nylia ® 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP) 0.5 mg/0.035 mg, 0.75 mg/0.035 mg and 1 mg/0.035 mg Rx only | 20220701 |
| 9c4aea9f-3bfb-4e84-b3c6-0324c81adedb | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20170726 |
| f6825c1a-ba78-47aa-9622-12e59517ab1a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | VIENVA TM | 20260303 |
| aa7f4a83-71cf-4306-b0a1-01784f67bae2 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | ELINEST™ (Norgestrel and Ethinyl Estradiol Tablets, USP) Rx only | 20251205 |
| 35eb35e6-d9a0-4472-94ac-aa470ccba567 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05 mg/0.03 mg, 0.075 mg/0.04 mg and 0.125 mg/0.03 mg Rx only | 20251202 |
| a8955f3b-afc9-4ef0-8946-9c97ab5b2e05 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE and ETHINYL ESTRADIOL Tablets, 3 mg/0.03 mg, for oral use Initial U.S. Approval: 2001. | 20251202 |
| b91ad328-f2f4-4f7d-82d3-daaada95f509 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) | 20250728 |
| ea9f7216-0358-43a9-96eb-5dad694ae9b8 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15mg/0.03 mg | 20240515 |
| 8381db98-f9b2-e894-c07e-5d49f10e4eea | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use Tri-Lo-Estarylla safely and effectively. See full prescribing information for Tri-Lo-Estarylla. Tri-Lo-Estarylla ® (norgestimate and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1989 | 20231221 |
| e1586633-1973-c396-6f4a-4c55cce4b59e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use SYEDA safely and effectively. See full prescribing information for SYEDA. SYEDA ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20230714 |
| c5270073-d083-4109-ae4b-156986175e0a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use NEXTSTELLIS safely and effectively. See full prescribing information for NEXTSTELLIS. NEXTSTELLIS ® (drospirenone and estetrol tablets), for oral use Initial U.S. Approval: 2021 | 20230511 |
| 7dbc4cdf-4ce2-5c66-343f-df381f56692a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | Isibloom ® (Desogestrel and Ethinyl Estradiol Tablets, USP) 0.15 mg/0.03 mg Rx only | 20230210 |
| 7a4d2d7b-b97e-3e18-3d97-1e2579c8f3f8 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use Estarylla safely and effectively. See full prescribing information for Estarylla. Estarylla ® (NORGESTIMATE and ETHINYL ESTRADIOL tablets) for oral use Initial U.S. Approval: 1989 | 20230201 |
| f5bc2427-3a18-e3e6-a058-210688e9c446 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use INTROVALE safely and effectively. See full prescribing information for INTROVALE. Introvale ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg for oral use Initial U.S. Approval: 1982 | 20220609 |
| 47263647-a9ac-40e4-83c0-d6500fa458cd | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 7 | Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/35 mcg | 20211216 |
| 175ce5c4-d332-4c97-a0b8-10821dc813ef | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 6 | Vyfemla™ (norethindrone and ethinyl estradiol tablets USP) 0.4 mg/0.035 mg | 20251119 |
| 2bd1b72e-fba5-4275-a02a-ed08a5434a92 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 6 | Cyonanz TM (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg Rx only | 20211203 |